[Current status of Helicobacter pylori eradication therapy. Significance of roxithromycin].
Bock
H
H
Internistische Praxis mit gastroenterologischem Schwerpunkt, Frankfurt/Main.
Mares
A
A
D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D005756:Gastritis / Q000188:drug therapy*; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000187:drug effects*; D006801:Humans; D008297:Male; D010437:Peptic Ulcer / Q000188:drug therapy*; D015575:Roxithromycin / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D015575:Roxithromycin